# A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers

> **NCT03038711** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 213 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** BMS-986166
- **OTHER:** Placebo matching BMS-986166

## Key facts

- **NCT ID:** NCT03038711
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-01
- **Primary completion:** 2017-08-10
- **Final completion:** 2017-08-10
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2019-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03038711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03038711, "A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03038711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*